Health CanadaGeneral Alert
ATARAX (hydroxyzine) - Risk of QT Prolongation and Torsade de Pointes
Published: June 6, 2016Recall ID: 55452Category: generalCountry: Canada
Safety AlertHealth Canada
Canada
ATARAX (hydroxyzine) - Risk of QT Prolongation and Torsade de Pointes
Recalling Firm: Marketed health products
Product Description & Identification
ATARAX (hydroxyzine) - Risk of QT Prolongation and Torsade de Pointes
Additional Source Details
| Field | Value |
|---|---|
| N I D | 55452 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/atarax-hydroxyzine-risk-qt-prolongation-and-torsade-pointes |
| Title | ATARAX (hydroxyzine) - Risk of QT Prolongation and Torsade de Pointes |
| Archived | 1 |
| Category | Drugs |
| Last updated | 2016-06-06 |
| Organization | Marketed health products |
Check Other Products In Your Household
Free Safety ToolsSafety recalls are issued daily across foods, medications, vehicles, and electronics. Use our instant tools to check your home for active safety warnings:
Overview
- Recalling FirmMarketed health products
Recall Hazard Severity
Official Agency AlertCaution (Class III)
📢 Share Warning
Alert family and friends to keep them safe. Copy this quick alert message:
🚨 SAFETY ALERT: Marketed health products - ATARAX (hydroxyzine) - Risk of QT Prolongation and Torsade de Pointes Check if your household is affected: https://therecallfile.com/recalls/atarax-hydroxyzine-risk-of-qt-prolongation-and-torsade-de-pointes/CANADA-55452
Join Alertlist
Get instant email updates whenever critical safety recalls like this are published.
Support The Recall File
Help keep official recall alerts free, accessible, and fast for everyone.
Spread the WordATARAX (hydroxyzine) - Risk of QT Prolongation and Torsade de Pointes